Literature DB >> 6095701

Effects of etomidate on hormonal responses to surgical stress.

R J Fragen, C A Shanks, A Molteni, M J Avram.   

Abstract

The hormonal responses to surgical stress were examined in 10 patients scheduled for elective gynecologic laparotomy. Anesthesia was induced with either thiopental, 4 mg/kg, or etomidate, 0.35 mg/kg, and maintained with nitrous oxide and enflurane. Plasma cortisol, aldosterone, ACTH, and catecholamines were measured during the 24 h after the induction of anesthesia. The catecholamine responses of the patients whose anesthesia was induced with either drug were similar. The plasma ACTH concentrations for the etomidate group were greater than baseline values and the concentrations in the thiopental group (P less than 0.05) in the fourth and fifth hours. In the patients receiving thiopental, both cortisol and aldosterone concentrations were greater than the baseline value (P less than 0.05) in the second to fourth hours after induction. In the etomidate group, the plasma concentrations of cortisol were less than baseline values (P less than 0.05) in the first and second hours after induction of anesthesia and both cortisol and aldosterone were lower than those in the thiopental group (P less than 0.05) in the half to fourth hours after induction. These results confirm an earlier report of the suppression of cortisol after etomidate administration and, because aldosterone also was suppressed, suggests that etomidate exerts its effect by inhibiting early stages of steroidogenesis in the adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095701     DOI: 10.1097/00000542-198412000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  30 in total

Review 1.  Anesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus.

Authors:  Yuji Kadoi
Journal:  J Anesth       Date:  2010-07-17       Impact factor: 2.078

2.  Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.

Authors:  Joseph F Cotten; Stuart A Forman; Joydev K Laha; Gregory D Cuny; S Shaukat Husain; Keith W Miller; Hieu H Nguyen; Elizabeth W Kelly; Deirdre Stewart; Aiping Liu; Douglas E Raines
Journal:  Anesthesiology       Date:  2010-03       Impact factor: 7.892

Review 3.  Clinical and molecular pharmacology of etomidate.

Authors:  Stuart A Forman
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

4.  Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.

Authors:  Ervin Pejo; Yan Feng; Wei Chao; Joseph F Cotten; Ri Le Ge; Douglas E Raines
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

5.  Missing effect of etomidate on testosterone secretion in man.

Authors:  B Allolio; R Stuttmann; W Winkelmann
Journal:  Klin Wochenschr       Date:  1986-01-15

Review 6.  [Etomidate for intravenous induction of anaesthesia].

Authors:  C Dumps; D Bolkenius; E Halbeck
Journal:  Anaesthesist       Date:  2017-12       Impact factor: 1.041

7.  Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function.

Authors:  Joseph F Cotten; Ri Le Ge; Natalie Banacos; Ervin Pejo; S Shaukat Husain; James H Williams; Douglas E Raines
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

8.  Hypoadrenalism following trauma: is sepsis always necessary?

Authors:  Ian M Paquette; Kenneth W Burchard
Journal:  Int J Clin Exp Med       Date:  2008-10-08

Review 9.  Stress Hyperglycemia During Surgery and Anesthesia: Pathogenesis and Clinical Implications.

Authors:  Nadine E Palermo; Roma Y Gianchandani; Marie E McDonnell; Sara M Alexanian
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

Review 10.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.